Screener
Allogene Therapeutics ALLO Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Allogene Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Allogene Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034585
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net cash provided by financing activities | 21,122 | 13,990 |
| Net change in cash and cash equivalents and restricted cash | (21,379) | (32,763) |
| Cash and cash equivalents and restricted cash — beginning of period | 61,980 | 85,510 |
| Cash and cash equivalents and restricted cash — end of period | $40,601 | $52,747 |
| Non-cash operating activities: | ||
| Property and equipment purchases in accounts payable and accrued liabilities | $146 | — |
| Supplemental disclosure: | ||
| Cash paid for amounts included in the measurement of lease liabilities | $(3,233) | $(3,227) |
Item 1. Financial Statements - Unaudited
FAQ
- What is Allogene Therapeutics's cash & equivalents?
- Allogene Therapeutics (ALLO) reported cash & equivalents of $40.6M in Q1 2026.
- How has Allogene Therapeutics's cash & equivalents changed year-over-year?
- Allogene Therapeutics's cash & equivalents decreased by 23.0% year-over-year, from $52.75M to $40.6M.
- What is the long-term trend for Allogene Therapeutics's cash & equivalents?
- Over 5 years (2020 to 2025), Allogene Therapeutics's cash & equivalents has grown at a -20.3% compound annual growth rate (CAGR), from $192.8M to $61.98M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Allogene Therapeutics's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude